MPD: Phenotype measures mapped to VT:0004939, B cell morphology trait

Phenotype measures associated with ontology term
VT:0004939 'B cell morphology trait'

Navigate ontologies

All measures in this list are mapped to the ontology descendants of VT:0004939. None are mapped to VT:0004939 directly.

VT:0002458 B cell quantity
VT:0008215 immature B cell quantity

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Donahue5:6	Donahue5	immune cell quantification	(none)	B cells (percentage of viable WBC) [%] pct_B_cells 41406	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue6:6	Donahue6	immune cell quantification	(none)	B cells (percentage of viable WBC) [%] pct_B_cells 41506	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Farmer1:36	Farmer1	immune cell quantification	(none)	percentage of viable B220⁺ B cells in 150 µl collected blood [%] B220 11336	QTL population		both	6wks	N=206	2001

Farmer1:37	Farmer1	immune cell quantification	(none)	percentage of viable IgM⁺ B cells in 150 µl collected blood [%] lgM 11337	QTL population		both	6wks	N=206	2001

Hackstein1:13	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD19+ B cells (percentage of CD45+ cells) [%] B_cells 49113	inbred	5	m	7-11wks	N=8	2012

Jaxpheno6:9	Jaxpheno6	immune cell quantification	(none)	splenic B cells (percentage of total viable cells) [%] pct_B 23109 8wks 16wks	inbred	11	both		N=9	2006

Lesage2:10	Lesage2	immune cell quantification	(none)	number of B cells in spleen (x 10⁶) [n] B_cells_tot 131925	CC w/par	76	both	5-8wks	N=2	2024

Lesage2:11	Lesage2	immune cell quantification	(none)	percentage of splenic lymphocytes that are B cells (CD3-CD49b-B220+CD19+) [%] B_cells_pct 131926	CC w/par	76	both	5-8wks	N=2	2024

Petkova1:25	Petkova1	immune cell quantification	(none)	B cells, as percentage of total lymphocytes [%] B_cells 24225 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Wiltshire4:1	Wiltshire4	immune cell quantification	BEZ235	B cells, percent viability [%] Bcells_BEZ 52401 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:21	Wiltshire4	immune cell quantification	doxorubicin	B cells, percent viability [%] Bcells_Dox 52421 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:41	Wiltshire4	immune cell quantification	idarubicin	B cells, percent viability [%] Bcells_Ida 52441 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:61	Wiltshire4	immune cell quantification	selumetinib	B cells, percent viability [%] Bcells_Sel 52461 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Filter Table Results